Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PCDHB1-AS1 (PCDHB1 antisense RNA 1) is a long non-coding antisense RNA transcribed from the region opposite the PCDHB1 gene, which belongs to the protocadherin beta gene cluster involved in neuronal cell-cell adhesion. Antisense lncRNAs like PCDHB1-AS1 can regulate the transcription of their sense counterparts (in this case, PCDHB1) through various epigenetic mechanisms, including modulation of promoter activity, chromatin structure, and DNA methylation states[1]. While sense and antisense transcriptional coupling is well-documented for the related protocadherin alpha cluster[1], and antisense lncRNAs are implicated in fine-tuning neuronal gene expression, specific functional or disease associations for PCDHB1-AS1 have not yet been established in the literature. It is not classified as a receptor, enzyme, or other classical drug target.\n\nIf you are seeking information about the protein-coding gene PCDHB1 (Protocadherin beta 1), that is a different entity, which belongs to the cadherin superfamily and is involved in neural adhesion and potentially neurodevelopmental processes[3][5].
Not applicable (no drugs currently target PCDHB1-AS1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PCDHB1 antisense RNA 1 (PCDHB1-AS1).